Back
BioMarin Pharmaceutical, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
BMRN
BioMarin Pharmaceutical, Inc.
Last Price:
$59.99
Seasonality Move:
-0.09%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and BMRN is experiencing slight buying pressure.
BioMarin Pharmaceutical, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.31 | Buy |
| 20-day SMA: | 61.09 | Sell |
| 50-day SMA: | 59.09 | Buy |
| 200-day SMA: | 56.62 | Buy |
| 8-day EMA: | 60.68 | Sell |
| 20-day EMA: | 60.45 | Sell |
| 50-day EMA: | 59.11 | Buy |
| 200-day EMA: | 58.7 | Buy |
BioMarin Pharmaceutical, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.51 | Buy |
| Relative Strength Index (14 RSI): | 50.93 | Buy |
| Chaikin Money Flow: | 169887 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.74 - 62.22) | Sell |
| Bollinger Bands (100): | (53.23 - 59.93) | Buy |
BioMarin Pharmaceutical, Inc. Technical Analysis
| Feb 26 | Feb 27 | Mar 2 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 9 | Mar 10 | Mar 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 26 | 27 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioMarin Pharmaceutical, Inc. Stock
Is BioMarin Pharmaceutical, Inc. Stock a Buy?
-
BioMarin Pharmaceutical, Inc. share price is 60.32 while BMRN 8-day simple moving average is 60.31, which is a Buy signal.
-
The stock price of BMRN is 60.32 while BioMarin Pharmaceutical, Inc. 20-day SMA is 61.09, which makes it a Sell.
-
BioMarin Pharmaceutical, Inc. 50-day simple moving average is 59.09 while BMRN share price is 60.32, making it a Buy technically.
-
BMRN stock price is 60.32 and BioMarin Pharmaceutical, Inc. 200-day simple moving average is 56.62, creating a Buy signal.
BMRN Technical Analysis vs Fundamental Analysis
Sell
36
BioMarin Pharmaceutical, Inc. (BMRN)
is a Sell
Is BioMarin Pharmaceutical, Inc. a Buy or a Sell?
-
BioMarin Pharmaceutical, Inc. stock is rated a SellThe current BioMarin Pharmaceutical, Inc. [BMRN] share price is $60.32. The Score for BMRN is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
BioMarin Pharmaceutical, Inc. Stock Info
Market Cap:
11.6B
Price in USD:
60.32
Share Volume:
2.5M
BioMarin Pharmaceutical, Inc. 52-Week Range
52-Week High:
73.18
52-Week Low:
50.76
Sell
36
BioMarin Pharmaceutical, Inc. (BMRN)
is a Sell
BioMarin Pharmaceutical, Inc. Share Price Forecast
-
What is the BioMarin Pharmaceutical, Inc. stock price today?The BioMarin Pharmaceutical, Inc. stock price is 60.32 USD today.
-
Will BMRN stock go up or go down?BioMarin Pharmaceutical, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is BioMarin Pharmaceutical, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioMarin Pharmaceutical, Inc. is overvalued.
Is BioMarin Pharmaceutical, Inc. Stock a Buy?
-
BioMarin Pharmaceutical, Inc. share price is 60.32 while BMRN 8-day exponential moving average is 60.68, which is a Sell signal.
-
The stock price of BMRN is 60.32 while BioMarin Pharmaceutical, Inc. 20-day EMA is 60.45, which makes it a Sell.
-
BioMarin Pharmaceutical, Inc. 50-day exponential moving average is 59.11 while BMRN share price is 60.32, making it a Buy technically.
-
BMRN stock price is 60.32 and BioMarin Pharmaceutical, Inc. 200-day simple moving average is 58.70, creating a Buy signal.
Fundamental Analysis of BioMarin Pharmaceutical, Inc.
Is BioMarin Pharmaceutical, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $1.07 per share, an increase next quarter of $0.08 per share, an increase this year of $2.08 per share, and an increase next year of $1.31 per share.
Technical Analysis of BioMarin Pharmaceutical, Inc.
Should I short BioMarin Pharmaceutical, Inc. stock?
-
BMRN Moving Average Covergence Divergence (MACD) indicator is 0.51, suggesting BioMarin Pharmaceutical, Inc. is a Buy
-
BioMarin Pharmaceutical, Inc. Relative Strength Index (RSI) is 50.93, which suggest BioMarin Pharmaceutical, Inc. is overbought
-
The Bollinger Bands (25) for BioMarin Pharmaceutical, Inc. is (58.74 - 62.22), which suggest BioMarin Pharmaceutical, Inc. is a Buy
-
The Bollinger Bands (100) for BioMarin Pharmaceutical, Inc. is (53.23 - 59.93), which suggest BioMarin Pharmaceutical, Inc. is a Buy
* BioMarin Pharmaceutical, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.